Literature DB >> 22984910

Comparison of intermittent pneumatic compression with manual lymphatic drainage for treatment of breast cancer-related lymphedema.

Sibel Ozkan Gurdal1, Alis Kostanoglu, Ikbal Cavdar, Ayfer Ozbas, Neslihan Cabioglu, Beyza Ozcinar, Abdullah Igci, Mahmut Muslumanoglu, Vahit Ozmen.   

Abstract

BACKGROUND: The aim of this prospective controlled study was to assess the efficacy of two different combination treatment modalities of lymphedema (LE). Manual lymphatic drainage (MLD) and compression bandage combination (complex decongestive therapy) have been compared with intermittent pneumatic compression (IPC) plus self-lymphatic drainage (SLD). METHODS AND
RESULTS: Both MLD with compression bandage (complex decongestive therapy) group (Group I, n=15) and IPC with SLD group (Group II, n=15) received treatment for LE 3 days in a week and every other day for 6 weeks. Arm circumferences were measured before and the 1st, 3rd, and 6th weeks of the treatment. EORTC-QLQ and ASES-tests were performed to assess the quality of life before and after 6 week-treatment. Patients in both groups had similar demographic and clinical characteristics. Even though both treatment modalities resulted in significant decrease in the total arm volume (12.2% decrease in Group II and 14.9% decrease in Group I) (p<0.001), no significant difference (p=0.582) was found between those two groups. Similarly, ASES scores were significantly (p=0.001) improved in both Group I and II without any significant difference between the groups. While emotional functioning, fatigue, and pain scores were significantly improved in both groups, global health status, functional and cognitive functioning scores appeared to be improved only in patients of group I.
CONCLUSIONS: Different treatment modalities consisting of MLD and compression bandage(complex decongestive therapy) or IPC and SLD appear to be effective in the treatment of LE with similar therapeutic efficacy in patients with breast cancer. However, combination modalities including IPC and SLD may be the preferred choices for their applicability at home.

Entities:  

Mesh:

Year:  2012        PMID: 22984910     DOI: 10.1089/lrb.2012.0002

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  14 in total

Review 1.  Manual lymphatic drainage for lymphedema following breast cancer treatment.

Authors:  Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak
Journal:  Cochrane Database Syst Rev       Date:  2015-05-21

2.  Low-level laser therapy in secondary lymphedema after breast cancer: systematic review.

Authors:  Mariana Toledo Biscaia Raposo Mourão E Lima; Januário Gomes Mourão E Lima; Mauro Figueiredo Carvalho de Andrade; Anke Bergmann
Journal:  Lasers Med Sci       Date:  2012-11-29       Impact factor: 3.161

Review 3.  Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

Authors:  Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

Review 4.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 5.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

6.  Pressures and timing of intermittent pneumatic compression devices for efficient tissue fluid and lymph flow in limbs with lymphedema.

Authors:  Marzanna Zaleska; Waldemar L Olszewski; Pradeep Jain; Sashi Gogia; Arun Rekha; Samsita Mishra; Marek Durlik
Journal:  Lymphat Res Biol       Date:  2013-12       Impact factor: 2.589

7.  Risk factors of breast cancer-related lymphedema.

Authors:  Saadet Ugur; Cumhur Arıcı; Muhittin Yaprak; Ayhan Mescı; Gulbin Ayse Arıcı; Kemal Dolay; Vahit Ozmen
Journal:  Lymphat Res Biol       Date:  2013-06       Impact factor: 2.589

8.  Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.

Authors:  Hoda E Sayegh; Maria S Asdourian; Meyha N Swaroop; Cheryl L Brunelle; Melissa N Skolny; Laura Salama; Alphonse G Taghian
Journal:  Curr Breast Cancer Rep       Date:  2017-05-03

9.  Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema.

Authors:  Hilal Yesil; Sibel Eyigör; İsmail Caramat; Rıdvan Işık
Journal:  Turk J Phys Med Rehabil       Date:  2017-11-13

10.  Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients.

Authors:  Sujin Noh; Ji Hye Hwang; Tae Hee Yoon; Hyun Ju Chang; In Ho Chu; Jung Hyun Kim
Journal:  Ann Rehabil Med       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.